Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose and Response of Intrathecal Hydromorphone in Patients Undergoing Cesarean Section at Virginia Commonwealth University Health System

NCT02787928 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT02787928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02787928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose and Response of Intrathecal Hydromorphone in Patients Undergoing Cesarean Section at Virginia Commonwealth University Health System
Lead sponsor
Virginia Commonwealth University
Phase
Phase 1
Overall status
Terminated
Start date
April 30, 2016
Completion date
December 31, 2017
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cesarean section, obstetric anesthesia